ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2022.0.179 2022.0.179 2022-09-302022-09-302true2021-10-01falseSpecialists medical practice activities2trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 12221500 2021-10-01 2022-09-30 12221500 2020-10-01 2021-09-30 12221500 2022-09-30 12221500 2021-09-30 12221500 c:Director2 2021-10-01 2022-09-30 12221500 d:FurnitureFittings 2021-10-01 2022-09-30 12221500 d:FurnitureFittings 2022-09-30 12221500 d:FurnitureFittings 2021-09-30 12221500 d:FurnitureFittings d:OwnedOrFreeholdAssets 2021-10-01 2022-09-30 12221500 d:CurrentFinancialInstruments 2022-09-30 12221500 d:CurrentFinancialInstruments 2021-09-30 12221500 d:CurrentFinancialInstruments d:WithinOneYear 2022-09-30 12221500 d:CurrentFinancialInstruments d:WithinOneYear 2021-09-30 12221500 d:ShareCapital 2022-09-30 12221500 d:ShareCapital 2021-09-30 12221500 d:RetainedEarningsAccumulatedLosses 2022-09-30 12221500 d:RetainedEarningsAccumulatedLosses 2021-09-30 12221500 d:AcceleratedTaxDepreciationDeferredTax 2022-09-30 12221500 d:AcceleratedTaxDepreciationDeferredTax 2021-09-30 12221500 c:FRS102 2021-10-01 2022-09-30 12221500 c:AuditExempt-NoAccountantsReport 2021-10-01 2022-09-30 12221500 c:FullAccounts 2021-10-01 2022-09-30 12221500 c:PrivateLimitedCompanyLtd 2021-10-01 2022-09-30 12221500 2 2021-10-01 2022-09-30 iso4217:GBP xbrli:pure

Registered number:  12221500














MY UPPER LIMB SURGEON LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2022


 
MY UPPER LIMB SURGEON LIMITED
REGISTERED NUMBER: 12221500

BALANCE SHEET
AS AT 30 SEPTEMBER 2022

2022
2021
Note
£
£

Fixed assets
  

Tangible assets
 4 
1,440
983

  
1,440
983

Current assets
  

Debtors: amounts falling due within one year
 5 
36,690
7,794

Cash at bank and in hand
 6 
93,649
55,924

  
130,339
63,718

Creditors: amounts falling due within one year
 7 
(24,355)
(13,898)

Net current assets
  
 
 
105,984
 
 
49,820

Total assets less current liabilities
  
107,424
50,803

Provisions for liabilities
  

Deferred tax
 8 
(360)
(246)

  
 
 
(360)
 
 
(246)

Net assets
  
107,064
50,557

Page 1

 
MY UPPER LIMB SURGEON LIMITED
REGISTERED NUMBER: 12221500
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2022

2022
2021
Note
£
£

Capital and reserves
  

Called up share capital 
  
2
2

Profit and loss account
  
107,062
50,555

  
107,064
50,557


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 26 June 2023.




S D Brookes-Fazakerley
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2022

1.


General information

My Upper Limb Surgeon Limited is a private company limited by shares incorporated in Engalnd and Wales under the Companies Act 2006; the company number is 12221500. The address of the registered office is C/O Langtons, The Plaza, 100 Old Hall Street, Liverpool, L3 9QJ.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2022

2.Accounting policies (continued)

 
2.4

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures and fittings
-
20%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 4

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2022

2.Accounting policies (continued)

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance sheet.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2021 - 2).

Page 5

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2022

4.


Tangible fixed assets





Fixtures and fittings

£



Cost or valuation


At 1 October 2021
1,229


Additions
879



At 30 September 2022

2,108



Depreciation


At 1 October 2021
246


Charge for the year on owned assets
422



At 30 September 2022

668



Net book value



At 30 September 2022
1,440



At 30 September 2021
983


5.


Debtors

2022
2021
£
£


Other debtors
27,495
5,882

Tax recoverable
9,195
1,912

36,690
7,794


Included within other debtors due within one year are loans to the following directors:
D M Brookes-Fazakerley - £11,580 (
2021: £nil)
S D Brookes-Fazakerley - £15,882 (
2012: £5,882)
The ;loans are unsecured and have no fixed repayment terms. Interest on the oustanding balances is charge at 2% p.a.

Page 6

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2022

6.


Cash and cash equivalents

2022
2021
£
£

Cash at bank and in hand
93,649
55,924

93,649
55,924



7.


Creditors: Amounts falling due within one year

2022
2021
£
£

Corporation tax
21,689
11,232

Accruals and deferred income
2,666
2,666

24,355
13,898



8.


Deferred taxation




2022


£






At beginning of year
(246)


Charged to profit or loss
(114)



At end of year
(360)

The provision for deferred taxation is made up as follows:

2022
2021
£
£


Accelerated capital allowances
(360)
(246)

(360)
(246)


9.


Controlling party

The company is controlle by its directors.

 
Page 7